Infantile form of muscle phosphofructokinase deficiency in a premature neonate

Pei-Ling Wu1, Yung-Ning Yang1, Shu-Leei Tey1

  • 1Department of Pediatrics, E-DA Hospital, School of Medicine, College of Medicine, I-Shou University, Kaohsiung, Taiwan.

Insights

Muscle phosphofructokinase (PFK) deficiency is a rare genetic disorder. Early recognition of infantile PFK deficiency, marked by hypotonia and contractures, is crucial for managing this severe condition.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Muscle phosphofructokinase (PFK) deficiency is a rare autosomal recessive metabolic disorder.
  • It affects glycolysis, impacting muscle energy production.

Observation:

  • A preterm infant presented with infantile PFK deficiency at 1 month corrected age.
  • Symptoms included floppy infant syndrome, joint contractures, cleft palate, and pelvicalyceal system duplication.
  • The infant succumbed to respiratory failure at 6 months corrected age.

Findings:

  • Review of infantile cases reveals common presentations: congenital hypotonia (78.6%) and arthrogryposis (64.3%).
  • Other systemic involvements include encephalopathy (35.7%) and cardiomyopathy (21.4%).
  • The infantile form of PFK deficiency has a notably low survival rate.

Implications:

  • Early diagnosis and recognition of multi-systemic involvement are critical for improved clinical management.
  • Understanding PFK deficiency's infantile manifestations aids in prognosis and supportive care strategies.
  • Further research into PFK deficiency can lead to novel therapeutic approaches.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
346
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
55.7K
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
7.2K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
786